Trials / Completed
CompletedNCT01679769
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 818 (actual)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China.
Detailed description
Up to Nov, 2015, total of 818 patients with chronic HBV infection had been enrolled in the study. Paired blood and liver biopsy specimen had been collected. The serum samples stored at -80 degree Celsius. All the liver biopsy samples were judged by three pathology experts, according to Ishak standard.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-10-01
- Completion
- 2015-11-01
- First posted
- 2012-09-06
- Last updated
- 2015-11-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01679769. Inclusion in this directory is not an endorsement.